It has been observed that aberrant activity of mutant human SOD1 in ALS patients leads to increase in the level of free radicals in CSF, serum, and urine samples of ALS patients, which exacerbates neuronal damage (Liu and Wang, 2017). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.